Poster Sessions

The following research projects were chosen to participate in the poster session:

New Technologies

Breast cancer biobanking: results of the PATH Biobank and contributing to MESI-STRAT
Charlotte Singrün, PATH Biobank

Biologically Vascularized Scaffold for Tissue Generation and Translation into Clinical Application
Sebastian Kress, Lehrstuhl Tissue Engineering und Regenerative Medizin (TERM), University Hospital Würzburg

TNFRSF antibody fusion proteins with targeting controlled agonistic activity independent of FcγRs
Juliane Medler, Division of Molecular Internal Medicine, Department of Internal Medicine II,
University Hospital Würzburg

CD40- and CD95-specific antibody:scBaff fusion proteins display BaffR-/TACI-/BCMA-restricted agonism
Johannes Nelke, Molecular Internal Medicine, University Hospital Würzburg

Synthesis and Characterization of NIR Dye-Doped Nanoparticles for in vivo Medical Imaging
Christine Schneider, Department Tissue Engineering and Regenerative Medicine (TERM),
University Hospital Würzburg

A data-driven approach to discover novel biomarkers by investigating complex immune cell patterns
Arno Schäpe, Ralf Schönmeyer, Definiens AG, Munich

Optimization of a novel TALEN targeting CCR5
Lea-Isabell Schwarze, Research Dept. Cell and Gene Therapy, Dept. of Stem Cell Transplantation,
University Medical Centre Hamburg-Eppendorf (UKE)

New Targets

50 Shades of Kinase Inhibition – Applications of the Target Landscape of Clinical Kinase Drugs
Stephanie Heinzlmeir, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)

The role of YB-1 in murine hematopoiesis
Viktoria Kunz, Department of Internal Medicine II, Translational Oncology, University Hospital Würzburg

Biosensing of labile glycoprotein-lipid complexes from serum as biomarkers for metabolic state
Günter A. Müller, Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München

Effects of p53 activity on therapy response against multiple myeloma
Umair Munawar, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg

New Therapies

A novel chimeric oncolytic virus vector for improved safety and efficacy as a cancer vivo-immunotherapy
Sarah Abdullahi, Department of Internal Medicine II, Klinikum rechts der Isar, TU München

Orthotic devices for oncologic and neuromuscular rehabilitation
João Miguel Quintino Guerreiro, University of Algarve (Faro, Portugal) - School of Health - Prosthetics and Orthotics Department

A novel strategy to treat advanced, late-stage tumors with Real-Time Tumor Vaccination
Dr. Piotr Jachimczak, RealTVac, Würzburg

Development of light-responsive cancer chemotherapeutics
Dr. Yelena Wainman, Department Pharmacy, LMU Munich